Longer tapering more effective for prescription opioid addiction

From Clinical Psychiatry News, 23 October 2013: Longer duration of buprenorphine tapering regime is significantly associated with superior outcomes in treatment for prescription opioid addiction, a double-blind randomized trial has found. The study was published online Oct. 23 in JAMA Psychiatry. “Our results suggest that a subset of [prescription opioid] abusers may respond favorably to Continue reading Longer tapering more effective for prescription opioid addiction

Parity laws appear to improve access to substance use disorder treatment

From Clinical Psychiatry News, 24 October 2013: The implementation of state-based parity legislation for specialty substance use disorder treatment is associated with significant improvements in access to treatment and treatment rates, new data show. “These findings suggest that the [Mental Health Parity and Addiction Equity Act] of 2008 and the [Affordable Care Act] of 2010 Continue reading Parity laws appear to improve access to substance use disorder treatment

Neuroimaging reveals characteristics of deficit schizophrenia

From Clinical Psychiatry News, 19 March 2013: The deficit subtype of schizophrenia is characterized by white matter tract disruption, while all subtypes of schizophrenia feature a reduction in cortical thickness, a cross-sectional neuroimaging study has found. Patients with deficit schizophrenia showed significant disruption of white matter at the right inferior longitudinal fasciculus, the right arcuate Continue reading Neuroimaging reveals characteristics of deficit schizophrenia

Genotype plays role in schizophrenia response to folate

From Clinical Psychiatry News, 19 March 2013: Folate and vitamin B12 supplements may improve the negative symptoms of schizophrenia but only in patients with a genetic variant that influences folate metabolism, a study has shown. “Although four such variants have previously been associated with negative symptom severity, the genotype that contributed most strongly to treatment Continue reading Genotype plays role in schizophrenia response to folate